Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc. (DWTX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · DWTX · as of Sep 30, 2025
Ownership Breakdown
12
Institutional Holders
▲ 2 vs Q2
$299,516
Total Inst. Value
▲ $91,972 vs Q2
1.91M
Shares Outstanding
freeFloat 70.86%
38,897
13F Shares Held
▼ 4,303 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
DWTX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC | 22.2K | 15.27% | 15.27% | $170.78M | Nov 7, 2025 | ▲ 10.4K |
GEODE CAPITAL MANAGEMENT, LLC | 15.1K | 10.39% | 10.39% | $116.16M | Nov 12, 2025 | ▲ 2.3K |
TOWER RESEARCH CAPITAL LLC (TRC) | 744 | 0.51% | 0.51% | $5.73M | Nov 14, 2025 | ▼ 48 |
MORGAN STANLEY | 600 | 0.41% | 0.41% | $4.62M | May 27, 2026 | ▼ 16.9K |
ACTIVEST WEALTH MANAGEMENT | 120 | 0.08% | 0.08% | $924,000 | Nov 3, 2025 | — held |
CITIGROUP INC | 99 | 0.07% | 0.07% | $762,000 | Nov 10, 2025 | NEW |
BLACKROCK, INC. | 30 | 0.02% | 0.02% | $231,000 | Nov 12, 2025 | — held |
BANK OF AMERICA CORP /DE/ | 16 | 0.01% | 0.01% | $123,000 | Feb 3, 2026 | ▼ 1 |
BNP PARIBAS ARBITRAGE, SNC | 10 | 0.01% | 0.01% | $77,000 | Nov 13, 2025 | NEW |
GROUP ONE TRADING, L.P. | 9 | 0.01% | 0.01% | $69,000 | Nov 12, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
2
Increased
+12.7K shares3
New Positions
first time holders4
Decreased
−17.1K shares1
Sold Out
fully exitedNet shares change (top 50)
4.4K
+12.7K / −17.1K
Net new holders
+0
3 new / 1 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
DWTX insider trading · insider activity
Source: SEC Form 4
4
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Grosswald Ralph SVP OF OPERATIONS | Mar 5, 2026 | Award | 82,500 | $2.86 | $235.9K | 82.5K | Form 4 ↗ |
Walsh Angela Chief Financial Officer | Mar 5, 2026 | Award | 82,500 | $2.86 | $235.9K | 82.5K | Form 4 ↗ |
Gendreau Roger Michael CHIEF MEDICAL OFFICER | Mar 5, 2026 | Award | 82,500 | $2.86 | $235.9K | 82.5K | Form 4 ↗ |
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Mar 5, 2026 | Award | 330,000 | $2.86 | $943.8K | 330.0K | Form 4 ↗ |
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Dec 4, 2025 | Award | 460,000 | $6.14 | $2.82M | 460.0K | Form 4 ↗ |
Walsh Angela Chief Financial Officer | Dec 4, 2025 | Award | 150,000 | $6.14 | $921.0K | 150.0K | Form 4 ↗ |
Grosswald Ralph SVP OF OPERATIONS | Dec 4, 2025 | Award | 150,000 | $6.14 | $921.0K | 150.0K | Form 4 ↗ |
Gendreau Roger Michael CHIEF MEDICAL OFFICER | Dec 4, 2025 | Award | 150,000 | $6.14 | $921.0K | 150.0K | Form 4 ↗ |
Sealbond Ltd See Remarks | Nov 21, 2025 | C-Conversion | 21,610,950 | $0.00 | $2.2K | 21.82M | Form 4 ↗ |
Sealbond Ltd See Remarks | Nov 21, 2025 | C-Conversion | 2,842,638 | $0.00 | $284.264 | 2.84M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Dogwood Therapeutics, Inc. (DWTX) is primarily owned by institutional investors, who hold approximately 2.0% of total shares outstanding. Company insiders own approximately 29.14%, while retail and public investors account for the remaining 68.82%.
The largest institutional shareholder of Dogwood Therapeutics, Inc. is VANGUARD GROUP INC, holding approximately 22,179 shares — equal to 15.27% of outstanding shares — as of September 30, 2025.
A total of 12 institutional investors currently hold DWTX stock, with a combined institutional value of approximately $299,516 as of the most recent 13F filing period.
Frequently asked questions
DWTX ownershipDogwood Therapeutics, Inc. (DWTX) is primarily owned by institutional investors, who hold approximately 2.0% of shares. The largest shareholder is VANGUARD GROUP INC with a 15.27% stake. Company insiders hold 29.14%. Data sourced from SEC Form 13F as of September 30, 2025.